Market revenue in 2021 | USD 1.7 million |
Market revenue in 2030 | USD 4.1 million |
Growth rate | 10.5% (CAGR from 2021 to 2030) |
Largest segment | Plants |
Fastest growing segment | Plants |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Animal, Plants, Synthetic |
Key market players worldwide | Amyris, Sophim, Kuraray Co Ltd, Croda International PLC, Arbe Robotics Ltd |
Plants was the largest segment with a revenue share of 88.24% in 2021. Horizon Databook has segmented the Benelux squalene market based on animal, plants, synthetic covering the revenue growth of each sub-segment from 2018 to 2030.
Benelux includes three countries, namely, Belgium, the Netherlands, and Luxembourg. These countries witness a surged demand for squalene owing to the flourishing pharmaceuticals and cosmetics industries. Belgium has emerged as the central point for vaccine production in Europe owing to its exceptional supply chain network.
This is expected to fuel the growth of squalene market in Benelux in the coming years. Shark liver oil-based squalene is highly effective in the production of vaccines as it increases the immune response of vaccines. However, the surging usage of squalene may cause the extinction of sharks in Benelux in the near future. As a result, plant-based alternatives are preferred in vaccine formulations in Benelux.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account